names of glp 1 injections Market Overview: GLP-1 Agonists and the Obesity Market | Blog Decoding GLP-1 Weight Loss Medications
Description
Nithin Kamath asked the same question publicly and called India a weird market
2020 global estimate and projected number of adults through 2035 with an overweight BMI [1]. Obesity is a significant independent risk factor contributing to numerous chronic conditions, including diabetes, hypertension, cardiovascular disease, and obstructive sleep apnea syndrome
Elevate your wellness today
Eli Lilly Chief Corporate Brand Officer Lina Polimeni on how the brand differentiates itself in the crowded pharma market, including with its GLP-1 medications.
Important: This product is NOT a GLP-1 receptor agonist
